poisar

Stock

Bionano Genomics, Inc. BNGO

$0.82-15.25%

Options

BNGO options chain

Explore expirations, strikes, liquidity, live quotes and Greeks in the context of the same company overview.

Options Chain SnapshotA bounded snapshot of up to 200 active contracts in the displayed expiration and strike window. Close and open interest are reference fields, not live quotes.

Up to 200 active BNGO contracts expiring in the next 7–45 days, with strikes within ±25% of the current price.

No active options contracts for BNGO in this window right now.

Source
US listed-options contracts feed
Observed
Cadence
Five-minute cached contract snapshot
Status
fresh

Live Quotes & GreeksThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Live bid/ask, implied volatility and Greeks for the nearest-expiry contracts are members-only.

Create account to unlock

Options Ideas & Decision IntelligenceThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Scored options ideas and decision intelligence for this underlying are members-only.

Create account to unlock

Asset BackgroundSource-supported background about this asset. The sources and review status are listed with the reference.

BNGO options refer to Bionano Genomics, Inc. as their underlying. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue.

AI-selected reference, checked against source evidence · Evidence observed

Frequently Asked QuestionsSource-linked answers to common questions about this asset. Check the evidence observation date and whether the reference was reviewed by a person.

What business does Bionano Genomics, Inc. operate?
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue.
How do BNGO options relate to the underlying company?
The published options record identifies BNGO as an underlying symbol. Options contracts reference that underlying; expiration, strike and option type define each separate contract.

What to WatchAI-assisted topics for further research about this asset. These are educational prompts, not trading signals or recommendations.

  • Business activities described in the company reference
  • Original company disclosures and industry classification